DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6
James P.B. O’Connor(Cancer Research UK), Geoff J.M. Parker(Unknown), Gordon C. Jayson(The Christie NHS Foundation Trust), Susan Cheung(Manchester Academic Health Science Centre), F Maders(The Christie Hospital), Alan Jackson(North Carolina Agricultural and Technical State University), Andrew R. Clamp, Caleb Roberts(Manchester Academic Health Science Centre), Gerard Thompson(University of Edinburgh), Canberra Rose(Manchester Academic Health Science Centre), G. Buonaccorsi(Manchester Academic Health Science Centre), Y. Watson(Manchester Academic Health Science Centre), Brandon Whitcher(Royal Marsden NHS Foundation Trust)
Cited by 135
Related Papers
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
An Introduction to Wavelets and Other Filtering Methods in Finance and Economics
|Elsevier eBooks|2002|1.1k
DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease
|NeuroImage|2010|534
Variational Bayesian Inference for a Nonlinear Forward Model
|IEEE Transactions on Signal Processing|2008|504